BioDelivery Sciences International (FRA:BD5) 3-Year Dividend Growth Rate : 0.00% (As of Dec. 2021)

View and export this data going back to 2004. Start your Free Trial

What is BioDelivery Sciences International 3-Year Dividend Growth Rate?

BioDelivery Sciences International's Dividends per Share for the three months ended in Dec. 2021 was €0.00.

The historical rank and industry rank for BioDelivery Sciences International's 3-Year Dividend Growth Rate or its related term are showing as below:

FRA:BD5's 3-Year Dividend Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 10.2
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

BioDelivery Sciences International's Dividend Payout Ratio for the three months ended in Dec. 2021 was 0.00. As of today, BioDelivery Sciences International's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of BioDelivery Sciences International's 3-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, BioDelivery Sciences International's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioDelivery Sciences International's 3-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioDelivery Sciences International's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where BioDelivery Sciences International's 3-Year Dividend Growth Rate falls into.

BioDelivery Sciences International 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

BioDelivery Sciences International (FRA:BD5) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

BioDelivery Sciences International's Dividend Payout Ratio for the quarter that ended in Dec. 2021 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2021 )	/	EPS without NRI (Q: Dec. 2021 )
	=	0	/	0.549
	=	0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioDelivery Sciences International 3-Year Dividend Growth Rate Related Terms>

BioDelivery Sciences International (FRA:BD5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioDelivery Sciences International Inc (FRA:BD5) » Definitions » 3-Year Dividend Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

4131 ParkLake Avenue, Suite 225, Raleigh, NC, USA, 27612

Website

http://www.bdsi.com

BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.

BioDelivery Sciences International (FRA:BD5) Headlines

No Headlines